FDA 483 - Blue Chip Group, Inc - February 13, 2019

The FDA issued a Form 483 to Blue Chip Group, Inc. in Salt Lake City, UT, following an inspection that identified significant deficiencies in sanitation principles, allergen control, and personnel practices. Observations included inadequate cleaning of scoops used for allergen and non-allergen ingredients, improper handling of spilled allergen-containing materials, and poor employee hygiene practices during ready-to-eat product manufacturing. These issues indicate a risk of product contamination and allergen cross-contact.